Literature DB >> 24056008

Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.

Christian Heiss1, Mary N Burtnick, Rosemary A Roberts, Ian Black, Parastoo Azadi, Paul J Brett.   

Abstract

O-Polysaccharides (OPS) were isolated from purified Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharides by mild-acid hydrolysis and gel-permeation chromatography. 1-D and 2-D (1)H and (13)C NMR spectroscopy experiments revealed that the OPS antigens were unbranched heteropolymers with the following structures: Collectively, our results demonstrate that the predominant OPS antigens expressed by B. pseudomallei and B. mallei isolates are structurally more complex than previously described and provide evidence that different capping residues are used by these closely related pathogens to terminate chain elongation. Additionally, they confirm that Burkholderia thailandensis and B. pseudomallei express OPS antigens that are essentially identical to one another.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Burkholderia mallei; Burkholderia pseudomallei; Burkholderia thailandensis; Lipopolysaccharide; O-polysaccharide; Structure

Mesh：

Substances：

Year:  2013        PMID： 24056008      PMCID： PMC3923507          DOI： 10.1016/j.carres.2013.08.013

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


  40 in total

1.  Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.

Authors:  Ricky L Ulrich; David DeShazer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Structural analysis of glycans by NMR chemical shift prediction.

Authors:  Magnus Lundborg; Göran Widmalm
Journal:  Anal Chem       Date:  2011-01-31       Impact factor: 6.986

3.  Type VI secretion is a major virulence determinant in Burkholderia mallei.

Authors:  Mark A Schell; Ricky L Ulrich; Wilson J Ribot; Ernst E Brueggemann; Harry B Hines; Dan Chen; Lyla Lipscomb; H Stanley Kim; Jan Mrázek; William C Nierman; David Deshazer
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

4.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

5.  Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei.

Authors:  L E Bryan; S Wong; D E Woods; D A Dance; W Chaowagul
Journal:  Can J Infect Dis       Date:  1994-07

6.  Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Narisara Anuntagool; Stitaya Sirisinha
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

7.  Sequence determination of oligosaccharides and regular polysaccharides using NMR spectroscopy and a novel Web-based version of the computer program CASPER.

Authors:  Per-Erik Jansson; Roland Stenutz; Göran Widmalm
Journal:  Carbohydr Res       Date:  2006-03-27       Impact factor: 2.104

8.  Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.

Authors:  Michelle Nelson; Joann L Prior; M Stephen Lever; Helen E Jones; Timothy P Atkins; Richard W Titball
Journal:  J Med Microbiol       Date:  2004-12       Impact factor: 2.472

9.  The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.

Authors:  Mary N Burtnick; Paul J Brett; Sarah V Harding; Sarah A Ngugi; Wilson J Ribot; Narisara Chantratita; Angelo Scorpio; Timothy S Milne; Rachel E Dean; David L Fritz; Sharon J Peacock; Joanne L Prior; Timothy P Atkins; David Deshazer
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

10.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835
View more
  16 in total

Review 1.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

2.  Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Authors:  Andrew E Scott; Mary N Burtnick; Margaret G M Stokes; Adam O Whelan; E Diane Williamson; Timothy P Atkins; Joann L Prior; Paul J Brett
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

3.  Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification.

Authors:  Chanthiwa Wikraiphat; Natnaree Saiprom; Sarunporn Tandhavanant; Christian Heiss; Parastoo Azadi; Gumphol Wongsuvan; Apichai Tuanyok; Matthew T G Holden; Mary N Burtnick; Paul J Brett; Sharon J Peacock; Narisara Chantratita
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

4.  Structure Characterization, Antioxidant and Immunomodulatory Activities of Polysaccharide from Pteridium aquilinum (L.) Kuhn.

Authors:  Zhe-Han Zhao; Xian-Yan Ju; Kui-Wu Wang; Xin-Juan Chen; Hong-Xiang Sun; Ke-Jun Cheng
Journal:  Foods       Date:  2022-06-22

5.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

6.  Evaluation of Polysaccharide-Based Latex Agglutination Assays for the Rapid Detection of Antibodies to Burkholderia pseudomallei.

Authors:  Vichaya Suttisunhakul; Narisara Chantratita; Chanthiwa Wikraiphat; Vanaporn Wuthiekanun; Zakiya Douglas; Nicholas P J Day; Direk Limmathurotsakul; Paul J Brett; Mary N Burtnick
Journal:  Am J Trop Med Hyg       Date:  2015-06-29       Impact factor: 2.345

7.  Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.

Authors:  Vichaya Suttisunhakul; Vanaporn Wuthiekanun; Paul J Brett; Srisin Khusmith; Nicholas P J Day; Mary N Burtnick; Direk Limmathurotsakul; Narisara Chantratita
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

Review 8.  Assessing Bacterial Interactions Using Carbohydrate-Based Microarrays.

Authors:  Andrea Flannery; Jared Q Gerlach; Lokesh Joshi; Michelle Kilcoyne
Journal:  Microarrays (Basel)       Date:  2015-12-10

9.  Structural Relationship of the Lipid A Acyl Groups to Activation of Murine Toll-Like Receptor 4 by Lipopolysaccharides from Pathogenic Strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Authors:  Kirill V Korneev; Nikolay P Arbatsky; Antonio Molinaro; Angelo Palmigiano; Rima Z Shaikhutdinova; Mikhail M Shneider; Gerald B Pier; Anna N Kondakova; Ekaterina N Sviriaeva; Luisa Sturiale; Domenico Garozzo; Andrey A Kruglov; Sergei A Nedospasov; Marina S Drutskaya; Yuriy A Knirel; Dmitry V Kuprash
Journal:  Front Immunol       Date:  2015-11-23       Impact factor: 7.561

10.  Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.

Authors:  Andrew E Scott; Sarah A Ngugi; Thomas R Laws; David Corser; Claire L Lonsdale; Riccardo V D'Elia; Richard W Titball; E Diane Williamson; Timothy P Atkins; Joann L Prior
Journal:  J Immunol Res       Date:  2014-05-07       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.